4.5 Article

Galectin-3 in biliary atresia and other pediatric cholestatic liver diseases

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Rare sequence variants associated with the risk of non-syndromic biliary atresia

Satoshi Tamaoka et al.

Summary: In this study, genome-wide screening was performed on 15 Japanese patients with non-syndromic biliary atresia (BA) and 509 control individuals. The results show that rare damaging variants in MFHAS1 may be a risk factor for non-syndromic BA.

HEPATOLOGY RESEARCH (2023)

Article Gastroenterology & Hepatology

Predictive model containing gene signature and shear wave elastography to predict patient outcomes after Kasai surgery in biliary atresia

Guotao Wang et al.

Summary: This study aims to develop a comprehensive gene-clinical model based on two-dimensional shear wave elastography (2DSWE), liver gene expression, and other clinical parameters to predict response to Kasai portoenterostomy (KPE) surgery for infants with biliary atresia (BA). Using RNA sequencing analysis, differentially expressed gene patterns between BA and non-BA control samples were identified, and a nine-gene prognostic classifier was generated. A nomogram model based on the nine-gene classifier, age, preoperative 2DSWE, and albumin was constructed and validated, accurately predicting response to KPE for BA patients.

HEPATOLOGY RESEARCH (2023)

Article Pediatrics

Primary vs. salvage liver transplantation for biliary atresia: A retrospective cohort study

Dor Yoeli et al.

Summary: Kasai hepatoportoenterostomy is the standard treatment for children with biliary atresia, but many patients require salvage liver transplantation due to progression to end-stage liver disease. This study compared outcomes of primary and salvage liver transplantation in pediatric candidates with biliary atresia. The results showed that recipients of salvage liver transplant had higher waiting list and graft survival, while recipients with late failure had lower bilirubin levels and were less critically ill. However, there was no significant difference in waiting list, recipient, or graft survival between primary and salvage liver transplantation after early failure.

JOURNAL OF PEDIATRIC SURGERY (2022)

Article Surgery

OPTN/SRTR 2020 Annual Data Report: Liver

A. J. Kwong et al.

Summary: The COVID-19 pandemic had a significant impact on transplant programs and outcomes, but the number of liver transplants performed in the United States reached a record high. Living donation activity decreased, but the survival rates for patients with liver transplants continued to improve. The liver transplant waitlists for both adults and children decreased in size, and a new liver distribution policy based on acuity circles was implemented. The predominant indication for liver transplants among adults in 2020 was alcohol-associated liver disease.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Gastroenterology & Hepatology

Galectin-3 is overexpressed in advanced cirrhosis and predicts post-liver transplant infectious complications

Eduardo Cervantes-Alvarez et al.

Summary: This study found that patients with advanced cirrhosis have increased levels of Gal-3, which is significantly correlated with disease severity and inflammatory markers. Gal-3 can be used to discriminate cirrhosis and predict post-transplant infectious complications.

LIVER INTERNATIONAL (2022)

Article Biochemistry & Molecular Biology

The therapeutic potential of galectin-3 inhibition in fibrotic disease

R. J. Slack et al.

Summary: Galectin-3, a beta-galactoside-binding mammalian lectin, plays a crucial role in regulating cellular signaling by prolonging retention time or retarding lateral movement of cell surface receptors in the plasma membrane. It is involved in various cellular functions such as diffusion, compartmentalization, endocytosis, and the functionality of membrane receptors, and has been shown to be pro-fibrotic in multiple models of organ fibrosis. Additionally, there has been a significant increase in scientific literature investigating the role of Galectin-3 in fibrotic diseases and the clinical development of new Galectin-3 inhibitors over the past decade.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2021)

Review Immunology

Macrophage Polarization and Its Role in Liver Disease

Cheng Wang et al.

Summary: Macrophages play a crucial role in liver diseases, with their polarization being significantly important in the initiation and progression of liver diseases. Macrophage polarization involves various molecular mechanisms, including multiple signaling pathways. Further research on macrophage polarization is essential for understanding and treating liver diseases effectively.

FRONTIERS IN IMMUNOLOGY (2021)

Article Gastroenterology & Hepatology

The usefulness of immunohistochemical staining of bile tracts in biliary atresia

Joanna Cielecka-Kuszyk et al.

Summary: This study utilized immunohistochemical staining to evaluate ductular proliferation and ductal plate malformation in patients with biliary atresia, with CK19 immunohistochemical staining proving to be crucial in the detection of ductular proliferation.

CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)

Article Pediatrics

Society of pediatric liver transplantation: Current registry status 2011-2018

Scott A. Elisofon et al.

PEDIATRIC TRANSPLANTATION (2020)

Review Immunology

Innate Immunity and Pathogenesis of Biliary Atresia

Ana Ortiz-Perez et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children

Felipe Leite de Oliveira et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Gastroenterology & Hepatology

Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century

Jorge A. Bezerra et al.

HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Cytokine-Producing B Cells Promote Immune-Mediated Bile Duct Injury in Murine Biliary Atresia

Joseph Bednarek et al.

HEPATOLOGY (2018)

Review Biochemistry & Molecular Biology

Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z

Salvatore Sciacchitano et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemistry & Molecular Biology

IL-6 promotes M2 macrophage polarization by modulating purinergic signaling and regulates the lethal release of nitric oxide during Trypanosoma cruzi infection

Liliana M. Sanmarco et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)

Article Medicine, General & Internal

Diagnostic and Prognostic Significance of Various Histopathological Features in Extrahepatic Biliary Atresia

Shenbagam Jeevakarunyam Muthukanagarajan et al.

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2016)

Article Immunology

Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury

Vladislav Volarevic et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2015)

Article Pathology

M1-and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3

Kavindra Kumara Wijesundera et al.

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)

Article Medicine, General & Internal

Use of Corticosteroids After Hepatoportoenterostomy for Bile Drainage in Infants With Biliary Atresia The START Randomized Clinical Trial

Jorge A. Bezerra et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Review Pharmacology & Pharmacy

Functions of Galectin-3 and Its Role in Fibrotic Diseases

Liu-cheng Li et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)

Article Gastroenterology & Hepatology

Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo

Joy X. Jiang et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)

Article Gastroenterology & Hepatology

Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice

Vladislav Volarevic et al.

HEPATOLOGY (2012)

Article Pediatrics

Biliary atresia: cellular dynamics and immune dysregulation

Amy G. Feldman et al.

SEMINARS IN PEDIATRIC SURGERY (2012)

Article Toxicology

Role of Galectin-3 in Acetaminophen-Induced Hepatotoxicity and Inflammatory Mediator Production

Ana-Cristina Dragomir et al.

TOXICOLOGICAL SCIENCES (2012)

Review Biochemistry & Molecular Biology

Galectin-3:: An open-ended story

J Dumic et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)

Article Multidisciplinary Sciences

Galectin-3 regulates myofibroblast activation and hepatic fibrosis

NC Henderson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)